HLA class I expression shapes the tumor immune microenvironment and influences prognosis in prostate cancer.
Saved in:
| Title: | HLA class I expression shapes the tumor immune microenvironment and influences prognosis in prostate cancer. |
|---|---|
| Authors: | Likasitwatanakul P; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, MN, 55455, USA.; Department of Medicine, Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand., Besonen C; School of Medicine, Creighton University, Omaha, NE, 68178, USA., Tsai AK; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, MN, 55455, USA.; Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, 55455, USA., Sadeghipour N; Department of Medical Affairs, Caris Life Sciences, Irving, TX, 85040, USA., Elliott A; Department of Medical Affairs, Caris Life Sciences, Irving, TX, 85040, USA., Arafa AT; Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, 55455, USA., Passow R; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, MN, 55455, USA., Chesner L; Department of Urology, University of California San Francisco, San Francisco, CA, 94115, USA., Felices M; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, MN, 55455, USA.; Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, 55455, USA., Kennedy PR; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, MN, 55455, USA.; Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, 55455, USA., Patnaik A; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA., Narayan V; Department of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA., Hamrick J; Department of Medical Affairs, Caris Life Sciences, Irving, TX, 85040, USA., Sena LA; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, 21231, USA., Zorko NA; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, MN, 55455, USA.; Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, 55455, USA., Hwang JH; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, MN, 55455, USA. jhwang@umn.edu.; Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, 55455, USA. jhwang@umn.edu., Antonarakis ES; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, MN, 55455, USA. anton401@umn.edu.; Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, 55455, USA. anton401@umn.edu. |
| Source: | Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2026 Jun; Vol. 29 (2), pp. 425-434. Date of Electronic Publication: 2025 Oct 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9815755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5608 (Electronic) Linking ISSN: 13657852 NLM ISO Abbreviation: Prostate Cancer Prostatic Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
